Truist Financial Boosts Integer (NYSE:ITGR) Price Target to $150.00

Integer (NYSE:ITGR) had its price target hoisted by research analysts at Truist Financial from $145.00 to $150.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price objective suggests a potential upside of 14.31% from the company’s current price.

Other analysts also recently issued research reports about the company. Oppenheimer initiated coverage on Integer in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price objective for the company. Bank of America raised their price target on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Citigroup raised their price target on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st. Finally, Benchmark reissued a “buy” rating and issued a $130.00 target price on shares of Integer in a research note on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $138.00.

Integer Stock Up 1.5 %

Shares of NYSE ITGR traded up $1.98 during mid-day trading on Monday, reaching $131.22. 108,228 shares of the company traded hands, compared to its average volume of 310,841. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The stock has a market cap of $4.40 billion, a PE ratio of 45.43, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. The company’s fifty day moving average is $125.02 and its two-hundred day moving average is $120.12. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $131.87.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. During the same quarter in the prior year, the company earned $1.14 EPS. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year. On average, analysts expect that Integer will post 5.3 earnings per share for the current year.

Insider Transactions at Integer

In other Integer news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 2.00% of the stock is owned by corporate insiders.

Institutional Trading of Integer

Institutional investors have recently modified their holdings of the company. GSA Capital Partners LLP bought a new stake in shares of Integer in the first quarter valued at about $786,000. Blue Trust Inc. increased its position in shares of Integer by 460.4% in the second quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock valued at $658,000 after acquiring an additional 4,636 shares during the last quarter. UniSuper Management Pty Ltd acquired a new stake in shares of Integer in the first quarter valued at about $976,000. Moloney Securities Asset Management LLC acquired a new stake in shares of Integer in the first quarter valued at about $927,000. Finally, Congress Asset Management Co. MA increased its position in shares of Integer by 7.5% in the first quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after acquiring an additional 31,736 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.